Article
Personalized colon cancer care in 2010.
Seminars in oncology - 1 Apr 2011
Catenacci Daniel V T, Kozloff Mark, Kindler Hedy L, Polite Blase
Abstract excerpt
Colon cancer (CC) therapies have improved patient outcomes significantly over the last decades in both the adjuvant and metastatic settings. With the introduction of a number of novel agents, both traditional chemotherapies and biologically targeted agents, the need to identify subgroups that are likely and not likely to respond to a particular treatment regimen is paramount. This will allow patients who are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
